| oshpd_id | manufacturer_name | date_reported | ndc_number | drug_product_description | wac_effective_date | wac_increase_amount | wac_after_increase | patent_expiration_date | drug_source_type | unit_sales_volume_in_us | unit_sales_volume_non_public_indicator | cost_increase_factors | cost_increase_factors_non_public_indicator | change_improvement_description | change_improvement_non_public_indicator | acquisition_date | company_acquired_from | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | wac_at_acquisition | wac_year_prior_to_acquisition | year_drug_introduced_to_market | wac_at_intro_to_market | supporting_documents | general_comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rx0000247 | Dendreon Pharmaceuticals LLC | 12/31/2020 | 30237890006 | Provenge Infusion, 250 ML, 1 per package | 10/01/2020 | 2247.48 | 64850.00 | 12/01/2015 | Single Source Drug | None | 1 | None | 1 | None | 1 | 06/27/2017 | Valeant | 819900000 | None | NA | 44382.94 | None | 2010 | 31000.00 | None | NA |
| Rx0000247 | Dendreon Pharmaceuticals LLC | 06/30/2020 | 30237890006 | Provenge, Infusion, 250 ml, 1 per package | 04/01/2020 | 3487.77 | 62602.52 | 12/01/2015 | Single Source Drug | None | 1 | None | 1 | None | 1 | 06/27/2017 | Valeant | 819900000 | None | NA | 44382.94 | 40492.98 | 2010 | 31000.00 | None | NA |